NCT03262727 The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients Status COMPLETED Phase PHASE1
NCT03255382 A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy Status COMPLETED Phase PHASE3
NCT03254784 A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation Status COMPLETED Phase PHASE1
NCT03254667 LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis Status ENROLLING_BY_INVITATION Phase N/A
NCT03253666 Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) Status COMPLETED Phase N/A
NCT03240809 An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03236870 A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China Status COMPLETED Phase N/A
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service Status COMPLETED Phase N/A
NCT03219437 A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03218488 A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03210259 The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03202004 GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis Status WITHDRAWN Phase PHASE3
NCT03201978 A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects Status WITHDRAWN Phase PHASE1
NCT03198390 Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions Status TERMINATED Phase N/A
NCT03180866 Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis Status UNKNOWN Phase NA
NCT03179605 Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 Status TERMINATED Phase PHASE2
NCT03173144 Chronic Inflammatory Disease, Lifestyle and Treatment Response Status COMPLETED Phase N/A
NCT03145948 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis Status TERMINATED Phase PHASE1